Medtronic Book Value Per Share 2010-2025 | MDT

Current and historical book value per share for Medtronic (MDT) from 2010 to 2025. Book value per share can be defined as the amount of equity available to shareholders expressed on a per common share basis. Medtronic book value per share for the three months ending April 30, 2025 was $38.66.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $108.260B $33.537B
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.485B 27.83
Boston Scientific (BSX) United States $154.809B 38.76
Stryker (SYK) United States $144.946B 30.31
EssilorLuxottica (ESLOY) France $134.105B 0.00
Haleon (HLN) United Kingdom $50.025B 28.46
Lonza Group Ag (LZAGY) Switzerland $49.059B 0.00
ResMed (RMD) United States $36.038B 27.07
GE HealthCare Technologies (GEHC) United States $31.860B 15.13
Agilent Technologies (A) United States $31.051B 20.51
Terumo (TRUMY) Japan $27.450B 35.65
Insulet (PODD) United States $22.837B 89.64
Koninklijke Philips (PHG) Netherlands $22.023B 15.83
Zimmer Biomet Holdings (ZBH) United States $18.348B 11.78
Baxter (BAX) United States $15.616B 11.66
Smith & Nephew SNATS (SNN) United Kingdom $12.578B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.204B 21.59
Lantheus Holdings (LNTH) United States $5.198B 13.11
Prestige Consumer Healthcare (PBH) United States $4.172B 18.64
Perrigo (PRGO) Ireland $3.700B 9.38
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.362B 14.64
ICU Medical (ICUI) United States $3.218B 23.73
Envista Holdings (NVST) United States $2.820B 23.44
GN Store Nord (GNNDY) Denmark $2.097B 17.37
QuidelOrtho (QDEL) United States $2.000B 13.76
LeMaitre Vascular (LMAT) United States $1.841B 41.16
AtriCure (ATRC) United States $1.647B 0.00
Neogen (NEOG) United States $1.350B 17.28
Acuren (TIC) United States $1.305B 0.00
AdaptHealth (AHCO) United States $1.223B 12.41
Kestra Medical Technologies (KMTS) United States $1.186B 0.00
Green Thumb Industries (GTBIF) United States $1.169B 26.29
BioLife Solutions (BLFS) United States $1.049B 0.00
Phibro Animal Health (PAHC) United States $0.942B 12.05
InMode (INMD) Israel $0.898B 9.05
CeriBell (CBLL) United States $0.634B 0.00
Evolus (EOLS) United States $0.618B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.573B 0.00
Curaleaf Holdings (CURLF) Canada $0.554B 0.00
Owens & Minor (OMI) United States $0.531B 4.40
Valneva SE (VALN) France $0.527B 0.00
Capricor Therapeutics (CAPR) United States $0.508B 0.00
Tilray Brands (TLRY) Canada $0.436B 0.00
Surmodics (SRDX) United States $0.416B 0.00
SNDL (SNDL) Canada $0.344B 0.00
Cresco Labs (CRLBF) United States $0.338B 0.00
Canopy Growth (CGC) Canada $0.331B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
VAREX IMAGING (VREX) United States $0.315B 11.58
Aurora Cannabis (ACB) Canada $0.293B 52.20
Sanara MedTech (SMTI) United States $0.276B 0.00
Sanuwave Health (SNWV) United States $0.267B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Verano Holdings (VRNOF) United States $0.244B 0.00
Cerus (CERS) United States $0.239B 0.00
ZimVie (ZIMV) United States $0.237B 10.78
Biote (BTMD) United States $0.212B 5.95
Brainsway (BWAY) Israel $0.196B 52.00
OraSure Technologies (OSUR) United States $0.190B 0.00
Quanterix (QTRX) United States $0.187B 0.00
High Tide (HITI) Canada $0.186B 0.00
Omeros (OMER) United States $0.182B 0.00
Organigram Global (OGI) Canada $0.179B 0.00
TriSalus Life Sciences (TLSI) United States $0.176B 0.00
Utah Medical Products (UTMD) United States $0.173B 14.11
FitLife Brands (FTLF) United States $0.131B 16.07
Jin Medical (ZJYL) China $0.125B 0.00
Exagen (XGN) United States $0.123B 0.00
TerrAscend (TSNDF) Canada $0.113B 0.00
Agape ATP (ATPC) $0.105B 0.00
MacroGenics (MGNX) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Fonar (FONR) United States $0.085B 10.96
Quipt Home Medical (QIPT) United States $0.084B 0.00
InterCure (INCR) Israel $0.072B 0.00
Veru (VERU) United States $0.072B 0.00
Zynex (ZYXI) United States $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.066B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.055B 0.00
United Health Products (UEEC) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
United-Guardian (UG) United States $0.039B 13.44
Modular Medical (MODD) United States $0.035B 0.00
Rockwell Medical (RMTI) United States $0.034B 0.00
Safety Shot (SHOT) United States $0.029B 0.00
Nephros (NEPH) United States $0.024B 32.29
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00